This study investigates pancreatic neuroendocrine tumors. The purpose is to explore a treatment option for these tumors using radiofrequency ablation.
The study evaluates the effectiveness and safety of radiofrequency treatment on specific pancreatic tumors. It focuses on understanding how well this treatment works and its impact on patients.
- Who can participate: Adults aged 18 to 80 with a pancreatic mass less than 2cm, in good health, and with no significant complications can participate. Participants must have a confirmed neuroendocrine tumor and meet other specific medical criteria.
- Study details: Participants will undergo radiofrequency ablation treatment, which may involve 1 to 3 sessions. A placebo is not used in this study.
- Study timelines: The study will last 5 years.
How understandable was the trial content above?
Hard to understand
Easy to understand